These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
682 related articles for article (PubMed ID: 26226294)
1. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140 [TBL] [Abstract][Full Text] [Related]
4. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study. Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186 [TBL] [Abstract][Full Text] [Related]
6. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109 [TBL] [Abstract][Full Text] [Related]
7. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432 [TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887 [TBL] [Abstract][Full Text] [Related]
9. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016 [TBL] [Abstract][Full Text] [Related]
11. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222 [TBL] [Abstract][Full Text] [Related]
12. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers. Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275 [TBL] [Abstract][Full Text] [Related]
13. Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR. Rosing F; Meier M; Schroeder L; Laban S; Hoffmann T; Kaufmann A; Siefer O; Wuerdemann N; Klußmann JP; Rieckmann T; Alt Y; Faden DL; Waterboer T; Höfler D Microbiol Spectr; 2024 Jul; 12(7):e0002424. PubMed ID: 38829114 [TBL] [Abstract][Full Text] [Related]
14. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818 [TBL] [Abstract][Full Text] [Related]
15. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292 [TBL] [Abstract][Full Text] [Related]
16. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study. Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126 [TBL] [Abstract][Full Text] [Related]
17. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer. Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665 [TBL] [Abstract][Full Text] [Related]
18. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer. Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer. Yoshida H; Murono S; Ueno T; Nakanishi Y; Tsuji A; Hatano M; Endo K; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T Acta Otolaryngol; 2017 Jul; 137(7):773-777. PubMed ID: 28093931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]